14-day Premium Trial Subscription Try For FreeTry Free
Undoubtedly, Sorrento Therapeutics' Henry Ji has done a fantastic job marketing SRNE stock. But as the Covid-19 race narrows, the probability of winning declines significantly.
SRNE stock won't appeal to many investors at this time. Click for news on its big hope among many plays.
So, what's the play here? If its pandemic catalysts deliver, shares could soar back to double-digits.
Sorrento Therapeutics has been busy in recent weeks, which could be good news. But the moves also undercut the previous case for SRNE stock.

2 Smart Ways to Play Sorrento Therapeutics

09:22am, Thursday, 29'th Oct 2020
Sorrento Therapeutics has speculation written all over it. Here are two smart ways to place your bet on SRNE stock.
These two companies don't have recurring revenues to rely on.

7 Growth Stocks Running On Fumes

10:05am, Tuesday, 27'th Oct 2020
As the second wave of the pandemic sweeps across the nation, these seven growth stocks are struggling to stay afloat in the current environment. The post 7 Growth Stocks Running On Fumes appeared firs

Is Sorrento Therapeutics Stock a Buy?

07:00am, Sunday, 25'th Oct 2020
Sorrento's coronavirus pipeline could still turn out to be a major disappointment.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE